The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

We analyzed “Generally Recognized as Safe” notices received by the FDA, obtained via a Freedom of Information request, and found that of the 1,163 submitted by companies between 1997 and April ...

As Southeast Asia's health and wellness market rapidly evolves, consumer expectations are shifting toward multifunctional ...

FDA action aligns with a growing chorus of scientists, public health experts, and advocates warning against the public health ...

That year, Congress enacted laws that recognized large-scale compounding pharmacies as “503B outsourcing facilities” and required them to register with the FDA, meet best practices for ...

As pollen peaks for the season, the U.S. Food and Drug Administration is warning that some popular allergy medications could cause a rare but severe itching side effect.. The FDA said in a safety ...

Telomir Pharmaceuticals Confirms Telomir-1 Restores Vision and Retinal Structure in Age-Related Macular Degeneration (AMD) Animal Model Using FDA-Recognized Surrogate Endpoints ...

Telomir Pharmaceuticals Confirms Telomir-1 Restores Vision and Retinal Structure in Age-Related Macular Degeneration (AMD) Animal Model Using FDA-Recognized Surrogate Endpoints ...

Telomir Pharmaceuticals Confirms Telomir-1 Restores Vision and Retinal Structure in Age-Related Macular Degeneration (AMD) Animal Model Using FDA-Recognized Surrogate Endpoints ...

Telomir Pharmaceuticals Confirms Telomir-1 Restores Vision and Retinal Structure in Age-Related Macular Degeneration (AMD) Animal Model Using FDA-Recognized Surrogate Endpoints ...